These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6180022)

  • 1. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.
    Leung KH; Koren HS
    J Immunol; 1982 Oct; 129(4):1742-7. PubMed ID: 6180022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
    Leung KH; Koren HS
    J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell function in trisomy-21 (Down's syndrome).
    Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
    Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas.
    Greenberg AH; Miller V; Jablonski T; Pohajdak B
    J Immunol; 1984 Apr; 132(4):2129-34. PubMed ID: 6199424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins.
    Koren HS; Anderson SJ; Fischer DG; Copeland CS; Jensen PJ
    J Immunol; 1981 Nov; 127(5):2007-13. PubMed ID: 6170683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
    Goto T; Herberman RB; Maluish A; Strong DM
    J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.
    Lang NP; Ortaldo JR; Bonnard GD; Herberman RB
    J Natl Cancer Inst; 1982 Aug; 69(2):339-43. PubMed ID: 6180205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
    Hisano G; Hanna N
    J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH; D'Amore P; Rainey M
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.